EVAX — Evaxion A/S
—
Nasdaq ·
Health Care ·
Biotechnology ·
CIK 1828253 ·
Denmark
Last close
$3.40
Market Cap
$28.36M
52W High
$4.23
52W Low
$2.77
ADV30
368,318
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 0 | — | -3,819,000 | -3,629,000 | 23,642,000 | 18,440,000 | 10,435,000 |
| Dec 2025 | 0 | — | -4,052,000 | -5,918,000 | 28,408,000 | 23,234,000 | 11,369,000 |
| Sep 2025 | 7,492,000 | — | 3,023,000 | 4,618,000 | 29,737,000 | 10,572,000 | 13,138,000 |
| Jun 2025 | 37,000 | — | -4,340,000 | -4,831,000 | 22,449,000 | 14,746,000 | 16,223,000 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-133,724,000
Inventory
—
Receivables
$1,051,000
ST Investments
—
EBIT TTM
$-10,871,000
Pretax Income TTM
$-10,692,000
Interest Exp TTM
$-179,000
Analysts
4
Yahoo Snapshot (yfinance, live)
Total Revenue
$7,491,000
EBITDA
$-8,326,000
Free Cash Flow
$-5,134,875
Enterprise Value
$18,462,200
Total Cash
$14,000,000
Total Debt
$7,105,000
Shares Out
8,340,215
Trailing EPS
$-0.50
Book Value
$1.28
ROE
-109.9%
ROA
-26.0%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 7,528,000 | -9,234,000 | -7,707,000 | 28,408,000 | 11,369,000 | — | -6,625,000 |
| Dec 2024 | 3,344,000 | -14,732,000 | -10,567,000 | 12,485,000 | 14,137,000 | — | -12,940,000 |
| Dec 2023 | 73,000 | -22,197,000 | -22,125,000 | 12,889,000 | 17,618,000 | — | -17,691,000 |
| Dec 2022 | 0 | -25,264,000 | -23,169,000 | 22,025,000 | 13,722,000 | — | -25,774,000 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
—
NetIncome TTM
—
OpCashFlow TTM
—
Assets (Latest)
—
Forward EPS
$-0.01
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| DYAI | DYADIC INTERNATIONAL INC | $27.22M | $0.68 | — |
| GRML | Greenland Mines Ltd | $27.16M | $8.55 | — |
| ESLA | Estrella Immunopharma, Inc. | $31.97M | $0.74 | — |
| CVM | CEL SCI CORP | $24.27M | $1.38 | — |
| JSPR | Jasper Therapeutics, Inc. | $24.04M | $0.72 | — |
News headlines (Yahoo Finance, 1h cache)
Evaxion AS (EVAX) (Q2 2026) Earnings Call Highlights: Strong EVX-01 Data and Field Validation ...
2026-08-20 23:01 · Yahoo
Evaxion announces business update and second quarter 2026 financial results
2026-08-20 11:30 · Yahoo
Evaxion to announce business update and second quarter 2026 financial results on August 20, 2026
2026-08-14 12:00 · Yahoo
European Equities Traded in the US Rise in Thursday Trading
2026-08-13 15:14 · Yahoo
Evaxion to present three-year clinical efficacy data for personalized cancer vaccine EVX-01 at the ESMO Congress 2026
2026-07-17 11:15 · Yahoo
Evaxion presents new preclinical data for cytomegalovirus vaccine program EVX-V1
2026-07-12 13:30 · Yahoo
Evaxion to present new preclinical data for cytomegalovirus vaccine candidate EVX-V1 at the International Herpesvirus Workshop
2026-07-01 12:00 · Yahoo
Can Merck & Company (MRK)’s Stake in Evaxion A/S (EVAX) Validate the Potential of AI-Driven Vaccine Discovery?
2026-08-20 22:06 · Yahoo
European Equities Traded in the US as American Depositary Receipts Edge Higher in Monday Trading
2026-08-10 15:16 · Yahoo
European Equities Traded in the US as American Depositary Receipts Start Week Marginally Higher in Monday Trading
2026-07-27 15:13 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.